In vitro effects of calcium channel blockers and beta-adrenergic blocking agents on microsomal lipid peroxidation and cytochrome p-450 content

Experimental and Toxicologic Pathology

Volumn 51, Issue 4-5, 1999, Pages 277-281

  Alov, P ^a   Koleva, M ^a   Kastelova, A ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Atenolol; Beta adrenergic blocking agents; Calcium antagonists; Calcium channel blockers; Cytochrome p 450; Diltiazem; Lipid peroxidation; Nifedipine; Propranolol; Verapamil

Indexed keywords

ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; DILTIAZEM; NIFEDIPINE; PROPRANOLOL DERIVATIVE; VERAPAMIL;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG POTENCY; ENDOPLASMIC RETICULUM; LIPID ANALYSIS; LIPID PEROXIDATION; LIVER MICROSOME; MALE; NONHUMAN; PHOSPHOLIPID MEMBRANE; RAT; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS;

ANIMALIA;

EID: 0032807132     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(99)80005-0     Document Type: Conference Paper

References (24)

1. ARUOMA O, SMITH R, CECCHINI P, et al.: Free radical scavenging and inhibition of lipid peroxidation by beta blockers and by agents that interfere with calcium metabolism. Biochem Pharmacol 1991; 42: 735-743.
2. BUEGE J, AUST S: Microsomal lipid peroxidation. In Methods in Enzymology 1978; 65: 302-310. Ed. S. FLEISHER and L. PACKER. Academic Press, New York.
3. ENGELKE M, BERGMANN U, DIEHL H: Fluidity of the microsomal membrane and cytochrome-p450 reduction kinetics of pig liver microsomes as a consequence of organic solvent impact. Xenobiotica 1993; 23: 71-78.
4. GONCALVES T, CARVALHO A, OLIVERA NC: Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas. Eur J Pharmacol 1991; 204: 315-322.
5. JANERO D, BURGHARDT B: Antiperoxidant effects of dihydropyridine calcium antagonists. Biochem Pharmacol 1989; 38: 4344-4348.
6. JANERO D, BURGHARDT B, LOPEZ R: Protection of cardiac membrane phospholipids against oxidative injury by calcium antagonists. Biochem Pharmacol 1988; 37: 4197-4203.
7. KAGAN V, SAVOV M, SERBINOVA E: Mechanisms of disassembly of a mixed function oxygenase system in liver endoplasmatic reticulum: I. The role of peroxidation of membrane phospholipids. Acta Physiol Pharmacol Bulg 1984; 10: 73-81.
8. KASTELOVA A, STOYTCHEV TS: Effect of propranolol, pindolol and atenolol on drug-metabolizing enzyme systems after single administration in rats. Compt Rend Acad Bulg Sci 1993; 46(7): 119-122.
9. KASTELOVA A, STOYTCHEV TS: A possible mechanism of the effect of different beta adrenergic blocking agents on the hepatic oxidative metabolism. Abstracts of the 2nd Xenobiotic and Toxicity Workshop of Balkan Countries (Ioannina, Greece) 1995; 25.
10. KEHRER J: Free radicals as mediators of tissue injury and disease. Critical Rev Toxicol 1993; 23: 21-48.
11. KITADA M, KOMORI M, OHI H, et al.: Form-specific degradation of cytochrome p-450 by lipid peroxidation in rat liver microsomes. Res Commun Chem Pathol Pharmac 1989; 63: 175-178.
12. KOLEVA M, ALOV P: Effect of multiple administration of calcium antagonists on lipid peroxidation in rat liver microsomes. Gen Pharmacol 1996; 27: 891-893.
13. KOLEVA M, STOYTCHEV TS: On the enzyme-inducing action of calcium antagonists. Arch Toxicol 1993; 67: 294-296.
14. KULCSAR-GERGELY J: Action of beta-adrenoceptor blockers on liver function of rats. Arzneimittelforschung 1989; 39: 782-785.
15. MAK I, WEGLICKI W: Comparative antioxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemal membrane lipid peroxidation. Circ Res 1990; 66: 1449-1452.
16. MAK I, ARROYO NC, WEGLICKI W: Inhibition of sarcolemal carbon-centered free radical formation by propranolol. Circ Res 1989; 65: 1151-1156.
17. NARIMATSU S, WATANABE T, MASUBUCHI Y, et al.: Characterization of a chemically reactive propranolol metabolite that binds to microsomal proteins of rat liver. Chem Res Toxicol 1995; 8: 721-728.
18. OMURA T, SATO R: The carbon monooxide binding pigment of liver microsomes. Evidence for its hemoprotein nature. J Biol Chem 1964; 239: 2370-2378.
19. ONDRIAS K, MISIK V, STASKO A, et al.: Comparison of antioxidant properties of nifedipine and illuminated nifedipine with nitrosospin traps in low density lipoproteins and phosphatidylcholine liposomes. Biochem Biophys Acta 1994; 1211: 114-119.
20. 2+ antagonists on the oxidative metabolism in dissociated mammalian brain neurons. Brain Res 1993: 610: 172-175.
21. PRITCHARD J, SCHNECK D, HAYES A: The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite. Res Commun Chem Pathol Pharmacol 1980; 27: 211-222.
22. SUGAWARA I, TOBISE K, ONODERA S: Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 1994; 47: 887-892.
23. WEITMAN S, PHELAN A, LECH J, et al.: Propranolol-induced alterations in rat erythrocyte membrane fluidity and apparent phase-transition temperatures. A depth-dependent process. Biochem Pharmacol 1989; 38: 2949-2955.
24. WILLS E: Effect of lipid peroxidation on membrane-bound enzymes of endoplasmatic reticulum. Biochem J 1971; 123: 983-991.